Evidence map›Paper›PMID 34584971›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2021

Split-dose 1 L polyethylene glycol (PEG) with ascorbate is non-inferior to split-dose PEG with sodium picosulfate and magnesium citrate with similar tolerability: a randomized study.

Kumanan Nalankilli, David J Gibson, Shahzaib Anwar, Danny Con, Helen Chen, Robyn Secomb, Peter Gibson, Gregor Brown

Open access · goldAbstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Patient-reported outcomes and measures applied in individuals undergoing colonoscopy surveillance for colorectal cancer: a scoping review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kumanan NalankilliDepartment of Gastroenterology Alfred Health Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-7835-1113
David J GibsonDepartment of Gastroenterology Alfred Health Melbourne Victoria Australia.
Shahzaib AnwarDepartment of Gastroenterology Alfred Health Melbourne Victoria Australia.
Danny ConDepartment of Gastroenterology Eastern Health Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-4983-6103
Helen ChenDepartment of Gastroenterology Alfred Health Melbourne Victoria Australia.
Robyn SecombDepartment of Gastroenterology Alfred Health Melbourne Victoria Australia.
Peter GibsonDepartment of Gastroenterology Alfred Health Melbourne Victoria Australia.
Gregor BrownDepartment of Gastroenterology Alfred Health Melbourne Victoria Australia.
Alfred Health · AUEastern Health · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimPost-marketing studies comparing low-volume polyethylene glycol (PEG)-based regimens are limited. This randomized study aimed to compare the efficacy and tolerability of a novel 1-L low-volume PEG-based preparation: 1 L PEG+Asc (PEG3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride, and potassium chloride) with PEG+SPMC (PEG3350, sodium chloride, potassium chloride and sodium sulfate, sodium picosulfate, magnesium oxide, citric acid, and aspartame), prior to routine colonoscopy at an Australian tertiary referral center.

methodsOutpatients undergoing colonoscopy were randomized to receive either split-dose 1 L PEG+Asc or split-dose PEG+SPMC. Bowel preparation quality using the Boston Bowel Preparation Scale (BPPS), modified Aronchick scores, procedure time, cecal intubation, and adenoma detection rates were recorded. Patient compliance and tolerability were captured using a standardized questionnaire.

resultsA total of 173 patients were randomized, of whom 164 completed the study and were allocated to 1 L PEG+Asc (

conclusionsThe quality of bowel preparation achieved with 1 L PEG+Asc is non-inferior to that with PEG+SPMC, with similar tolerability outcomes. Further studies are required in patients at risk of suboptimal bowel preparation.

Indexed as

bowel preparationcolonoscopyPlenvuPrepkit‐Csplit‐dose

Identifiers

PMID34584971
PMCPMC8454467
OpenAlexW3194036241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.